Emcure Pharmaceuticals Releases FY26 Business Responsibility and Sustainability Report
Emcure Pharmaceuticals Ltd. has filed its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. The report, which forms an integral part of the company's Annual Report, details Emcure's commitment to responsible business practices, sustainable growth, ethical governance, and creating long-term stakeholder value. Key focus areas include enhancing healthcare accessibility globally, strengthening environmental stewardship through resource efficiency and emission reduction, fostering a safe and inclusive workplace, contributing to community development via CSR initiatives, and reinforcing governance through transparency and robust risk management. The company aims to integrate sustainability principles across its value chain and operations.
Key Highlights
- Emcure Pharmaceuticals filed its BRSR for FY 2025-26.
- Report highlights commitment to responsible business and sustainability.
- Focus on healthcare accessibility, environmental stewardship, and CSR.
- Strengthened governance and ethical conduct are key priorities.
- Sustainability integration across the value chain is emphasized.
Price Impact
More from EMCURE